Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children

J Antimicrob Chemother. 1999 Nov;44(5):709-15. doi: 10.1093/jac/44.5.709.

Abstract

Although there have been a number of studies in adults, to date there has been little research into sequential antimicrobial therapy (SAT) in paediatric populations. The present study evaluates the impact of a SAT protocol for the treatment of severe lower respiratory tract infection in paediatric patients. The study involved 89 paediatric patients (44 control and 45 SAT). The SAT patients had a shorter length of hospital stay (4.0 versus 8.3 days), shorter duration of inpatient antimicrobial therapy (4.0 versus 7.9 days) with the period of iv therapy being reduced from a mean of 5.6 to 1.7 days. The total healthcare costs were reduced by 52%. The resolution of severe lower respiratory tract infection with a short course of iv antimicrobials, followed by conversion to oral therapy yielded clinical outcomes comparable to those achieved using longer term iv therapy. SAT proved to be an important cost-minimizing tool for realizing substantial healthcare costs savings.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Amoxicillin-Potassium Clavulanate Combination / administration & dosage
  • Amoxicillin-Potassium Clavulanate Combination / economics
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use
  • Bronchitis / drug therapy*
  • Cefixime / administration & dosage
  • Cefixime / economics
  • Cefixime / therapeutic use
  • Cefotaxime / administration & dosage
  • Cefotaxime / economics
  • Cefotaxime / therapeutic use
  • Child
  • Child, Preschool
  • Clinical Protocols
  • Drug Administration Schedule
  • Female
  • Health Care Costs
  • Humans
  • Infant
  • Injections, Intravenous
  • Length of Stay
  • Male
  • Pneumonia / drug therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination
  • Cefixime
  • Cefotaxime